London

London, Ontario N6A4G5

0 studies enrolling now · 2 studies all time

What they study most

C. Diff, C. Difficile, CDI, Clostridium Difficile Infection, FMT, Fecal Microbiota, Fecal Transplant, Prostate Cancer, Recurrent C. Diff, Recurrent CDI, Recurrent Clostridium Difficile Infection, rCDI

Studies at this site

• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed
• A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer — Completed